PubMed:10328107 / 321-535
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 51-72 | cell_type | denotes | malignant lymphocytes |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S3 | 0-214 | Sentence | denotes | We investigated the effects of As2O3 on a panel of malignant lymphocytes to determine whether growth-inhibitory and apoptotic effects of As2O3 can be observed in these cells at clinically achievable concentrations. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C7 | 31-36 | NP | denotes | As2O3 |
| C8 | 51-72 | NP | denotes | malignant lymphocytes |
| C9 | 137-142 | NP | denotes | As2O3 |
| C10 | 162-173 | NP | denotes | these cells |
| C11 | 177-213 | NP | denotes | clinically achievable concentrations |
| R4 | C9 | C7 | coref-ident | As2O3,As2O3 |
| R5 | C10 | C8 | coref-ident | these cells,malignant lymphocytes |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 31-36 | other_organic_compound | denotes | As2O3 |
| T11 | 51-72 | cell_type | denotes | malignant lymphocytes |
| T12 | 137-142 | other_organic_compound | denotes | As2O3 |